Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions
Flare Therapeutics, a biotechnology company targeting transcription factors to discover precision medicines for cancer and […]
Sensorion Appoints Khalil Barrage as Interim Chairman of the Board
Sensorion, a pioneering clinical-stage biotechnology company that specializes in gene therapies in the ear, announces […]
Glyscend Therapeutics Appoints Biotech Industry Veteran Michael Wyzga to its Board of Directors
Glyscend Therapeutics, a clinical-stage biotechnology company pioneering a new generation of orally administered polymer therapies, […]
Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases
Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), today […]
Xeris Biopharma Appoints Ricki Fairley to Board of Directors
Xeris Biopharma, a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing […]
Genialis Raises $13M in Financing to Build Clinical Biomarkers that Predict Patient Response
Genialis, a computational precision medicine company unraveling complex biology to find new ways to address […]
MIMETAS and Astellas Enter into Strategic Partnership
MIMETAS, a global leader in human disease modeling, announces that it has entered into a […]
Ratio Therapeutics Announces Licensing Agreement for Investigational PET Imaging Agent with Merck
Ratio Therapeutics, a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class […]
Sonoma Biotherapeutics and Regeneron Announce Collaboration to Discover, Develop and Commercialize T Cell Therapies
Sonoma Biotherapeutics and Regeneron Pharmaceuticals today announced a collaboration to apply their scientific and clinical expertise […]
Avacta Appoints Karen Harrison as Chief Operating Officer for Therapeutics Division
Avacta Group, a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, today […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more